Level of maternal respiratory syncytial virus (RSV) F antibodies in hospitalized children and correlates of protection

RSV neutralizing antibodies at birth predict protection from RSV illness in infants in the first three months of life

(2020) Andrea G Buchwald et al.   CLINICAL INFECTIOUS DISEASES

A proof of concept for structure-based vaccine design targeting RSV in humans

(2019) Michelle C. Crank et al.   SCIENCE

Transplacental transfer of maternal respiratory syncytial virus (RSV) antibody and protection against RSV disease in infants in rural Nepal

(2017) Helen Y. Chu et al.   JOURNAL OF CLINICAL VIROLOGY

Maternal immunisation: collaborating with mother nature

(2017) Arnaud Marchant et al.   LANCET INFECTIOUS DISEASES

Vaccine development for respiratory syncytial virus

(2017) Barney S Graham   Current Opinion in Virology

A novel pre-fusion conformation-specific neutralizing epitope on the respiratory syncytial virus fusion protein

(2017) Jarrod J. Mousa et al.   Nature Microbiology

Taxonomy of the order Mononegavirales: update 2016

(2016) Claudio L. Afonso et al.   ARCHIVES OF VIROLOGY

WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23–24 March 2015

(2016) Kayvon Modjarrad et al.   VACCINE

Determinants of early life immune responses to RSV infection

(2016) Tracy J Ruckwardt et al.   Current Opinion in Virology

The Real-Life Effectiveness of Palivizumab for Reducing Hospital Admissions for Respiratory Syncytial Virus in Infants Residing in Nunavut

(2016) Anna Banerji et al.   Canadian Respiratory Journal

RSV infections: State of the art

(2015) G. PIEDIMONTE   CLEVELAND CLINIC JOURNAL OF MEDICINE

Challenges and Opportunities in Developing Respiratory Syncytial Virus Therapeutics

(2015) E. A. F. Simoes et al.   JOURNAL OF INFECTIOUS DISEASES

Prefusion F–specific antibodies determine the magnitude of RSV neutralizing activity in human sera

(2015) Joan O. Ngwuta et al.   Science Translational Medicine

A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism

(2015) Anders Krarup et al.   Nature Communications

Respiratory Syncytial Virus Transplacental Antibody Transfer and Kinetics in Mother-Infant Pairs in Bangladesh

(2014) Helen Y. Chu et al.   JOURNAL OF INFECTIOUS DISEASES

Maternal Antibodies: Clinical Significance, Mechanism of Interference with Immune Responses, and Possible Vaccination Strategies

(2014) Stefan Niewiesk   Frontiers in Immunology

Maternal immunization as a strategy to decrease susceptibility to infection in newborn infants

(2013) Benjamin Lindsey et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Molecular Characterization of Circulating Respiratory Syncytial Virus (RSV) Genotypes in Gilgit Baltistan Province of Pakistan during 2011-2012 Winter Season

(2013) Uzma Bashir Aamir et al.   PLoS One

Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody

(2013) J. S. McLellan et al.   SCIENCE

Strategic priorities for respiratory syncytial virus (RSV) vaccine development

(2013) L.J. Anderson et al.   VACCINE

Transplacental transport of IgG antibodies to preterm infants: A review of the literature

(2010) J.P. van den Berg et al.   EARLY HUMAN DEVELOPMENT

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

(2010) Harish Nair et al.   LANCET

Modified Recommendations for Use of Palivizumab for Prevention of Respiratory Syncytial Virus Infections

(2009)   PEDIATRICS